Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment-Reference-Cited by-同舟云学术

Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment

Published:2020-09-11 Issue:11 Volume:17 Page:1597-1613
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Sorolla Anabel¹,Sorolla Maria Alba²,Wang Edina¹,Ceña Valentín³⁴^ORCID

Affiliation:

1. Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, The University of Western Australia, Crawley, Australia

2. Biomedical Research Institute (IRB Lleida), Research Group of Cancer Biomarkers, Lleida, Spain

3. Unidad Asociada Neurodeath, Universidad De Castilla-La Mancha, Albacete, Spain

4. Centro De Investigación En Red Sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, Spain

Funder

Raine Medical Research Foundation

Marie Skłodowska-Curie Individual fellowship

Spanish Ministerio de Economía y Competitividad

Junta de Comunidades de Castilla-La Mancha

ISCIII and ERANET Euronanomed Program

COST

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2020.1814733

Reference132 articles.

1. Cancer statistics, 2020

2. Molecular portraits of human breast tumours

3. Comprehensive molecular portraits of human breast tumours

4. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

5. Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells;Nanomedicine;2024-05-29

2. Dermaseptin B2 bioactive gene’s potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway;Medical Oncology;2024-05-20

3. Nanoscale strides: exploring innovative therapies for breast cancer treatment;RSC Advances;2024

4. Organic and Biogenic Nanocarriers as Bio-Friendly Systems for Bioactive Compounds’ Delivery: State-of-the Art and Challenges;Materials;2023-12-07

5. Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells;Vaccines;2023-12-02